First direct evidence of HPV-related tonsillar cancer on the rise in Canada

August 13, 2013
First direct evidence of HPV-related tonsillar cancer on the rise in Canada
This is Dr. David Palma, Scientist at Lawson Health Research Institute (Lawson) and Ontario Institute for Cancer Research, and Dr. Anthony Nichols, also a Scientist at Lawson. Credit: Lawson Health Research Institute

American and European research shows an alarming increase in the rate of tonsillar cancer related to the human papilloma virus (HPV), a sexually transmitted virus. Experts suggest a similar trend has emerged in Canada, but it had yet to be confirmed through scientific analysis. In a new study published in Current Oncology, a group of researchers from Lawson Health Research Institute and Western University have produced evidence confirming this epidemic.

Orophararyngeal impacts part of the throat, including the tonsils and the base of the tongue. Historically, these types of throat cancers were caused by smoking and alcohol use, but recent studies show that HPV is now a major cause. When an individual contracts HPV, the virus's DNA can infiltrate healthy cells and induce cancer years later.

As sexually-transmitted diseases become increasingly common, American and European data shows the rates of HPV-related tonsillar cancer are also climbing at an alarming rate. To assess the impact in Canada, a team of researchers led by Drs. Anthony Nichols, David Palma, who is also a Clinician-Scientist at the Ontario Institute for Cancer Research, and Marina Salvadori led a retrospective study of patients at London Health Sciences Centre (LHSC).

Looking at three different time periods – 1993-1999, 2000-2005, and 2006-2011 – the study team searched the LHSC for patients with tonsillar cancer diagnosed during those time periods. The team then reviewed each patient's chart for information on diagnosis, treatment, and follow-up, and analyzed their biopsy samples to determine whether HPV was present in their DNA.

In total, 160 patient records were identified with sufficient data for analysis. HPV was detected in 57% of cases, most commonly amongst young non-smokers. Results show the incidence of these cancers rose significantly over each time period. Over the same period, treatment generally evolved from radiation to a concurrent mix of chemotherapy and radiation. Survival rates also improved significantly; recurrence free survival increased from 53% to 82%, and 5-year survival rates increased from 37% to 83%.

While these results show positive patient outcomes, they also suggest serious complications for the available health resources in Canada. Unlike traditional throat cancer patients, those with HPV-related tonsillar cancer are younger, healthier, and more likely to survive their disease. New treatments allow them to live longer, but also expose them to more concentrated levels of toxicity, and make them more reliant on health care resources for a longer period of time. Existing vaccinations can help to prevent this disease, but uptake across the nation has been limited.

"Based on this data, we can anticipate a major impact on the Canadian health care system and the patients it serves," says Dr. Nichols. "We now need to seriously consider strategies to prevent the disease including vaccinations, and to continue to develop better treatments with fewer side effects in order to preserve patient quality of life."

Explore further: HPV a growing cause of upper throat cancer (Update)

More information: www.current-oncology.com/index … gy/article/view/1375

Related Stories

HPV a growing cause of upper throat cancer (Update)

June 3, 2013
Actor Michael Douglas' comments about throat cancer have thrown a spotlight on cancer risks from a sexually spread virus. The virus, HPV, is best known for causing cervical cancer. But experts say it also is a growing cause ...

HPV improves survival for African-Americans with throat cancer

March 28, 2013
Even though the human papillomavirus (HPV) is a risk factor for certain head and neck cancers, its presence could make all the difference in terms of survival, especially for African Americans with throat cancer, according ...

HPV leaves its mark in oropharyngeal squamous cell carcinoma

May 1, 2013
Oropharyngeal squamous cell carcinoma (OPSCC) is a form of cancer that affects the cells lining the middle part of the throat, including the soft palate, the base of the tongue, the tonsils, and the pharynx.

HPV improves survival for African-Americans with throat cancer

July 19, 2012
Even though the human papillomavirus (HPV) is a risk factor for certain head and neck cancers, its presence could make all the difference in terms of survival, especially for African Americans with throat cancer, say Henry ...

Vaccinating boys plays key role in HPV prevention

July 22, 2013
Improving vaccination rates against the human papillomavirus (HPV) in boys is key to protecting both men and women, says new research from University of Toronto Professor Peter A. Newman from the Factor-Inwentash Faculty ...

Hidden strains of HPV found in 'virus-negative' genital warts

July 11, 2013
There are 170 established HPV types. Cancerous human papillomavirus (HPV) viruses are the main cause of cervical cancer, and are found in close to 100% of cervical tumors.

Recommended for you

Stem cell therapy attacks cancer by targeting unique tissue stiffness

July 26, 2017
A stem cell-based method created by University of California, Irvine scientists can selectively target and kill cancerous tissue while preventing some of the toxic side effects of chemotherapy by treating the disease in a ...

Understanding cell segregation mechanisms that help prevent cancer spread

July 26, 2017
Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.

Study uncovers potential 'silver bullet' for preventing and treating colon cancer

July 26, 2017
In preclinical experiments, researchers at VCU Massey Cancer Center have uncovered a new way in which colon cancer develops, as well as a potential "silver bullet" for preventing and treating it. The findings may extend to ...

Compound shows promise in treating melanoma

July 26, 2017
While past attempts to treat melanoma failed to meet expectations, an international team of researchers are hopeful that a compound they tested on both mice and on human cells in a petri dish takes a positive step toward ...

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.